Iovance Biotherapeutics(GB:0JDK)
$8.03+0.04 (+0.56%)
GB:0JDK
Iovance Biotherapeutics hedge funds
$8.03
At close:+0.04 (+0.56%)
Iovance Biotherapeutics (0JDK) Hedge Fund Trading Activity
5 Followers
Trend: ▲ Hedge Funds Increased Holdings by 45.2K Shares Last Quarter
Hedge Fund Holdings in 0JDK
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 Joseph Edelman | Perceptive Advisors LLC | New | 100.00% | $416,909 | <0.01% | ||
 Michael Rockefeller | Woodline Partners LP | Not Changed | 0.00% | $1,549,766 | <0.01% | ||
| Michael Lee-Chin | Portland Investment Counsel Inc. | Not Changed | 0.00% | $354,900 | 0.11% | ||
| Andrew J.M. Spokes | Farallon Capital Management, L.L.C. | Not Changed | 0.00% | $70,980 | <0.01% |
FAQ
Which hedge funds hold Iovance Biotherapeutics?
The hedge funds that hold the most shares in Iovance Biotherapeutics are Michael Rockefeller, Joseph Edelman and Michael Lee-Chin.
Are hedge funds buying or selling GB:0JDK?
In the last quarter hedge funds have Increased their holdings in Iovance Biotherapeutics by 45.2K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Iovance Biotherapeutics stock?
Warren Buffet currently does not own shares in Iovance Biotherapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
